ArticleFrontiers in microbiology2020
Antimicrobial Resistance and Virulence-Associated Markers in
Article in Frontiers in microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed.
- High-Resolution Genomic Profiling ofMicroorganisms · 2026Article
- Prevalence, antibiotic resistance, resistance and virulence determinants ofOne health (Amsterdam, Netherlands) · 2025Review
- Comparative Genomic Analysis ofMicroorganisms · 2025Article
- New Campylobacter Lineages in New Zealand Freshwater: Pathogenesis and Public Health Implications.Environmental microbiology · 2024Article
- Genotypic characterization and antimicrobial susceptibility of humanMicrobiology spectrum · 2024Article
- Review
- A Decade of Antimicrobial Resistance in Human and AnimalAntibiotics (Basel, Switzerland) · 2024Review
- Bibliometric analysis and evaluation of publications on non-Future microbiology · 2024Review
- Article
- Genomic and clinical characteristics of campylobacteriosis in Australia.Microbial genomics · 2024Article
- Prevalence, antibiotic resistance, and genomic characterisation ofMicrobial genomics · 2024Article
- Campylobacter jejuni and Campylobacter coli in human stool samples: antibiotic resistance profiles, putative virulence determinants and molecular characterization of the isolates.World journal of microbiology & biotechnology · 2023Article
- Genomic and Antimicrobial Surveillance ofFoods (Basel, Switzerland) · 2023Article
- Genomic Analysis and Antimicrobial Resistance ofChina CDC weekly · 2023Article
- Antimicrobial resistance inMicrobial genomics · 2023Article
- Overview of Virulence and Antibiotic Resistance inAntibiotics (Basel, Switzerland) · 2023Review
- Genomic diversity, virulence and source of Campylobacter jejuni contamination in Irish poultry slaughterhouses by whole genome sequencing.Journal of applied microbiology · 2022Article
- Should We Consider Them as a Threat? Antimicrobial Resistance, Virulence Potential and Genetic Diversity ofAntibiotics (Basel, Switzerland) · 2022Article
- Prevalence, Antimicrobial Resistance, and Molecular Characterization ofMicrobiology spectrum · 2022Article
- Emergence of Erythromycin Resistance Methyltransferases in Campylobacter coli Strains in France.Antimicrobial agents and chemotherapy · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Campylobacteriosis is one of the most common causes of bacterial gastroenteritis. However, the clinical course of the illness varies in symptoms and severity. The aim of this study was to characterize
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.